Hormonal contraception
Baillargeon, J., McClish, D., Essah, P. and Nestler, J. (2005). Association between the Current Use of Low-Dose Oral Contraceptives and Cardiovascular Arterial Disease: A Meta-Analysis. . The Journal of Clinical Endocrinology and Metabolism., 90(7), 3863-3870.
Burrows, M., & Peters, C. E. (2007). The influence of oral contraceptives on athletic performance in female athletes. Sports Med, 37(7), 557-574. doi:10.2165/00007256-200737070-00001
Cea-Soriano, L., Garcia Rodriguez, L. A., Machlitt, A., & Wallander, M. A. (2014). Use of prescription contraceptive methods in the UK general population: a primary care study. BJOG, 121(1), 53-60; discussion 60-51. doi:10.1111/1471-0528.12465
Daniels, K., Daugherty, J., & Jones, J. (2014). Current contraceptive status among women aged 15-44: United States, 2011-2013. NCHS Data Brief(173), 1-8.
Kemmeren, J. M., Algra, A., & Grobbee, D. E. (2001). Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ, 323(7305), 131-134. doi:10.1136/bmj.323.7305.131
Khalili, H. (2016). Risk of Inflammatory Bowel Disease with Oral Contraceptives and Menopausal Hormone Therapy: Current Evidence and Future Directions. Drug Saf, 39(3), 193-197. doi:10.1007/s40264-015-0372-y
Konopka, J. A., Hsue, L. J., & Dragoo, J. L. (2019). Effect of Oral Contraceptives on Soft Tissue Injury Risk, Soft Tissue Laxity, and Muscle Strength: A Systematic Review of the Literature. Orthopaedic journal of sports medicine, 7(3), 2325967119831061. https://doi.org/10.1177/2325967119831061
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431771/
Lebrun, C. M. (1993). Effect of the different phases of the menstrual cycle and oral contraceptives on athletic performance. Sports Med, 16(6), 400-430. doi:10.2165/00007256-199316060-00005
Martin, D., Sale, C., Cooper, S. B., & Elliott-Sale, K. J. (2018). Period Prevalence and Perceived Side Effects of Hormonal Contraceptive Use and the Menstrual Cycle in Elite Athletes. Int J Sports Physiol Perform, 13(7), 926-932. doi:10.1123/ijspp.2017-0330
https://pubmed.ncbi.nlm.nih.gov/29283683/
Rechichi, C., Dawson, B., & Goodman, C. (2009). Athletic performance and the oral contraceptive. Int J Sports Physiol Perform, 4(2), 151-162. doi:10.1123/ijspp.4.2.151
Schaumberg, M. A., Emmerton, L. M., Jenkins, D. G., Burton, N. W., Janse de Jonge, X. A. K., & Skinner, T. L. (2018). Use of Oral Contraceptives to Manipulate Menstruation in Young, Physically Active Women. Int J Sports Physiol Perform, 13(1), 82-87. doi:10.1123/ijspp.2016-0689
Wong, C. L., Farquhar, C., Roberts, H., & Proctor, M. (2009). Oral contraceptive pill for primary dysmenorrhoea. Cochrane Database Syst Rev(4), CD002120. doi:10.1002/14651858.CD002120.pub3
Baillargeon, J., McClish, D., Essah, P. and Nestler, J. (2005). Association between the Current Use of Low-Dose Oral Contraceptives and Cardiovascular Arterial Disease: A Meta-Analysis. . The Journal of Clinical Endocrinology and Metabolism., 90(7), 3863-3870.
Burrows, M., & Peters, C. E. (2007). The influence of oral contraceptives on athletic performance in female athletes. Sports Med, 37(7), 557-574. doi:10.2165/00007256-200737070-00001
Cea-Soriano, L., Garcia Rodriguez, L. A., Machlitt, A., & Wallander, M. A. (2014). Use of prescription contraceptive methods in the UK general population: a primary care study. BJOG, 121(1), 53-60; discussion 60-51. doi:10.1111/1471-0528.12465
Daniels, K., Daugherty, J., & Jones, J. (2014). Current contraceptive status among women aged 15-44: United States, 2011-2013. NCHS Data Brief(173), 1-8.
Kemmeren, J. M., Algra, A., & Grobbee, D. E. (2001). Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ, 323(7305), 131-134. doi:10.1136/bmj.323.7305.131
Khalili, H. (2016). Risk of Inflammatory Bowel Disease with Oral Contraceptives and Menopausal Hormone Therapy: Current Evidence and Future Directions. Drug Saf, 39(3), 193-197. doi:10.1007/s40264-015-0372-y
Konopka, J. A., Hsue, L. J., & Dragoo, J. L. (2019). Effect of Oral Contraceptives on Soft Tissue Injury Risk, Soft Tissue Laxity, and Muscle Strength: A Systematic Review of the Literature. Orthopaedic journal of sports medicine, 7(3), 2325967119831061. https://doi.org/10.1177/2325967119831061
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431771/
Lebrun, C. M. (1993). Effect of the different phases of the menstrual cycle and oral contraceptives on athletic performance. Sports Med, 16(6), 400-430. doi:10.2165/00007256-199316060-00005
Martin, D., Sale, C., Cooper, S. B., & Elliott-Sale, K. J. (2018). Period Prevalence and Perceived Side Effects of Hormonal Contraceptive Use and the Menstrual Cycle in Elite Athletes. Int J Sports Physiol Perform, 13(7), 926-932. doi:10.1123/ijspp.2017-0330
https://pubmed.ncbi.nlm.nih.gov/29283683/
Rechichi, C., Dawson, B., & Goodman, C. (2009). Athletic performance and the oral contraceptive. Int J Sports Physiol Perform, 4(2), 151-162. doi:10.1123/ijspp.4.2.151
Schaumberg, M. A., Emmerton, L. M., Jenkins, D. G., Burton, N. W., Janse de Jonge, X. A. K., & Skinner, T. L. (2018). Use of Oral Contraceptives to Manipulate Menstruation in Young, Physically Active Women. Int J Sports Physiol Perform, 13(1), 82-87. doi:10.1123/ijspp.2016-0689
Wong, C. L., Farquhar, C., Roberts, H., & Proctor, M. (2009). Oral contraceptive pill for primary dysmenorrhoea. Cochrane Database Syst Rev(4), CD002120. doi:10.1002/14651858.CD002120.pub3